Journal of Studies on Alcohol and Drugs
May 28, 2026
Cassidy R Loparco, Matthew E Rossheim, Kayla K Tillett et al.
Retail sales of intoxicants, including derived intoxicating cannabis products (DICPs) such as delta-8 tetrahydrocannabinol (THC) and hallucinogenic mushrooms, have rapidly increased throughout the US, despite their sale being federally illegal. This study assessed DICP and hallucinogenic mushroom availability in US smoke shops with differing DICP and psilocybin laws. In May-October 2025, using...
Journal of Studies on Alcohol and Drugs
May 20, 2025
Mark A. Prince, Brandon Paez, Jessica L Morse et al.
High school youth have an elevated risk of substance use. Some substances (e.g., inhalants, MDMA) used by youth are overlooked or grouped in an "other" category. Compared to other racial/ethnic groups, American Indian (AI) youth may be at higher risk of using these substances. The purpose of this study is to examine the prevalence and patterns of use of "other" substances among youth living on...
Journal of Studies on Alcohol and Drugs
September 1, 2024
Brian Rush, Olivia Marcus, Sara García et al.
12 citations
This article focuses on the outcomes at 1 year post-treatment of a naturalistic evaluation of services provided through the Takiwasi Centre, an accredited Peruvian therapeutic community offering an ayahuasca-assisted, integrative treatment program for addiction rehabilitation. Participants (n = 52) completed structured interviews and a battery of validated instruments. Outcome measures included...
Journal of Studies on Alcohol and Drugs
September 1, 2024
Anja Loizaga-Velder, Armando Loizaga Pazzi
4 citations
This article provides an intercultural transdisciplinary perspective on the Indigenous roots of the resurging field of psychedelic science in the management of substance use disorders (SUDs). Ritual uses of entheogens (i.e., psychedelics of natural origin) are elaborate technologies for navigating, containing, and therapeutically directing non-ordinary states of consciousness induced by these...
Journal of Studies on Alcohol and Drugs
September 1, 2024
Sisi Li, Taylor Kurtzweil, Shahin Shams et al.
3 citations
Recent research has shown potential for psychedelic therapeutics as addiction treatments; however, some academic institutions, commercial entities, and individuals are attempting to monopolize psychedelic compounds through exploiting the patent process. This Perspective article describes efforts that have been devised to mitigate exclusionary patent practices pertinent to psychedelic...
Journal of Studies on Alcohol and Drugs
September 1, 2024
Svět Lustig Vijay, Magdalena Harris, Fabio Friso et al.
1 citation
Ayahuasca, an entheogen from the Amazon rainforest, has garnered growing interest for treating substance dependence. To date, there is little research concerning the act of ayahuasca-related purging (mainly vomiting), which is considered to be central to healing during ayahuasca rituals. This study explored practitioner perspectives on purging during ayahuasca rituals at the Takiwasi Center in...
Journal of Studies on Alcohol and Drugs
August 23, 2024
Bethany A. Gray, Olivia L. Bolts, Deborah J. Fidler et al.
1 citation
Psilocybin use in nonclinical settings is heterogeneous. We identified three profiles that differed on frequency and quantity of use and their associated demographic characteristics. Next steps are to identify factors that affect one's likelihood of experiencing particular use outcomes and to explore use variability.
Journal of Studies on Alcohol and Drugs
May 1, 2023
Matthew E Rossheim, Cassidy R Loparco, Doug Henry et al.
41 citations
The 2018 U.S. Federal Agriculture Improvement Act ("Farm Bill") resulted in what some have called a "legal loophole" in cannabis regulation. As different types of cannabis products proliferate, so has the terminology used to attempt to categorize them. This article presents a variety of potential descriptors to encourage dialogue about the language used to classify the multitude of psychoactive...
Journal of Studies on Alcohol and Drugs
July 1, 2022
Timothy I. Michaels, Lebert Lester, Sara de la Salle et al.
19 citations
OBJECTIVE: Despite strong evidence for the safety and efficacy of ketamine in the treatment of mood disorders, the enrollment of Black, Indigenous, and People of Color (BIPOC) has not been a focus of this research. Health disparities in the treatment of mood disorders in BIPOC indicate a strong need to understand the clinical, social, and pharmacological aspects of this novel treatment in...
Journal of Studies on Alcohol and Drugs
July 1, 2020
Ilana Berlowitz, Heinrich Walt, Christian Ghasarian et al.
19 citations
Our results suggest that the Amazonian medicine-based therapy attracts a diverse patient group not limited to regional residents and may be particularly appealing to more impaired SUD patients with a history of unsuccessful treatment. The sample's cultural diversity suggests an existing interest in such therapies among international SUD treatment-seeking patients. These findings are relevant in...
Journal of Studies on Alcohol and Drugs
2020
Mark Haden, Birgitta Woods
31 citations
OBJECTIVE: In academic settings around the world, there is a resurgence of interest in using psychedelic substances for the treatment of addictions, posttraumatic stress disorder, depression, anxiety, and other diagnoses. This case series describes the medical consequences of accidental overdoses in three individuals. METHOD: Case series of information were gathered from interviews, health...
Journal of Studies on Alcohol and Drugs
May 1, 2019
Mark A. Prince, Maeve B. O’donnell, Linda R. Stanley et al.
16 citations
OBJECTIVE: Some American Indians legally use hallucinogenic substances as part of religious and spiritual ceremonies. Research to date has either failed to differentiate spiritual versus recreational use or has categorized hallucinogen use in an "other drug" or "illegal drug" category. This approach could contribute to ineffectual models of prevention and treatment intervention and limit...